Tag #Precision Medicine

Showing 1 to 12 of 16 results

repubblica.it

🌐 85% Global Worthiness

Sep 22, 04:16

Cardiologists in Italy Call for More Cardioradiologists to Improve Cardiovascular Care

Italian cardiologists are calling for an increase in the number of cardioradiologists to improve the timeliness and accuracy of cardiovascular diagnoses, citing advancements in technology and the need for personalized medicine.

Cardiologists in Italy Call for More Cardioradiologists to Improve Cardiovascular Care

Italian cardiologists are calling for an increase in the number of cardioradiologists to improve the timeliness and accuracy of cardiovascular diagnoses, citing advancements in technology and the need for personalized medicine.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the primary concern raised by Italian cardiologists regarding cardiovascular care?

The primary concern is the shortage of cardioradiologists in Italian hospitals. This shortage delays timely, accurate, and less-invasive diagnoses, potentially leading to worse patient outcomes. The lack of cardioradiologists hinders the adoption of advanced diagnostic tools and personalized medicine approaches.

elpais.com

🌐 85% Global Worthiness

Jun 23, 13:17

Genomic Instability Test Predicts Chemotherapy Failure in Cancer Patients

Researchers in Spain and the UK have developed a new genomic instability analysis that predicts which patients will not respond to three major chemotherapy types, impacting treatment decisions and potentially reducing side effects for up to 50% of patients.

Genomic Instability Test Predicts Chemotherapy Failure in Cancer Patients

Researchers in Spain and the UK have developed a new genomic instability analysis that predicts which patients will not respond to three major chemotherapy types, impacting treatment decisions and potentially reducing side effects for up to 50% of patients.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the significance of the new genomic instability analysis for cancer treatment?

Researchers at the CNIO have developed a new genomic instability analysis that can predict which patients will not respond to three major classes of chemotherapy: platinum, taxane, and anthracycline. This is significant because up to 50% of patients do not respond to these drugs, yet still suffer their side effects. The analysis was validated using data from over 800 patients with ovarian, breast, prostate, and sarcoma tumors.

roma.repubblica.it

🌐 75% Global Worthiness

Jun 12, 19:11

Rome Oncology Conference: Integrating Care and Precision Medicine

A two-day oncology conference in Rome (June 13-14) will focus on integrating hospital and territorial care and precision medicine to improve cancer treatment and patient outcomes in Italy, aligning with the National Recovery and Resilience Plan (PNRR).

Rome Oncology Conference: Integrating Care and Precision Medicine

A two-day oncology conference in Rome (June 13-14) will focus on integrating hospital and territorial care and precision medicine to improve cancer treatment and patient outcomes in Italy, aligning with the National Recovery and Resilience Plan (PNRR).

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the main goals of the oncology conference in Rome, and what specific changes are anticipated for the Italian healthcare system?

A two-day oncology conference in Rome, from June 13-14, will focus on integrating hospital and territorial care, along with precision medicine. The event, sponsored by the Order of Physicians of Rome and Sapienza University of Rome, aims to redefine Italy's oncology approach, improving patient care and outcomes.

news.sky.com

🌐 85% Global Worthiness

Jun 1, 16:13

New Drug Shows Significant Promise in Reducing Breast Cancer Progression

A clinical trial shows that the drug camizestrant reduces breast cancer progression by 52% compared to standard treatments, offering a potential breakthrough in precision medicine by using blood tests to detect treatment resistance early.

New Drug Shows Significant Promise in Reducing Breast Cancer Progression

A clinical trial shows that the drug camizestrant reduces breast cancer progression by 52% compared to standard treatments, offering a potential breakthrough in precision medicine by using blood tests to detect treatment resistance early.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How did the use of blood tests in the Serena-6 trial contribute to the success of camizestrant?

The Serena-6 trial, involving over 3000 patients, demonstrated that camizestrant stabilizes cancer for approximately 16 months on average, compared to 9 months with other treatments. This success is linked to using blood tests to detect treatment resistance early, allowing for timely therapy adjustments. The trial highlights the potential of ctDNA analysis to personalize advanced breast cancer care.

welt.de

🌐 75% Global Worthiness

May 22, 19:12

German University Secures €140 Million in Research Funding

The Christian-Albrechts-University in Kiel, Germany, received renewed funding totaling approximately €140 million for two research clusters—one on precision medicine for chronic inflammation and the other on past human-environment interactions—securing its eligibility for "Excellence University" sta...

German University Secures €140 Million in Research Funding

The Christian-Albrechts-University in Kiel, Germany, received renewed funding totaling approximately €140 million for two research clusters—one on precision medicine for chronic inflammation and the other on past human-environment interactions—securing its eligibility for "Excellence University" sta...

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the significance of the CAU's continued funding for its excellence clusters in the context of Germany's national research strategy?

The Christian-Albrechts-University (CAU) in Kiel, Germany, secured continued funding for two of its excellence clusters: "Precision Medicine in Chronic Inflammation" and "Roots - Connectivity of Society, Environment, and Culture in Past Worlds." Each cluster receives roughly €70 million until 2032.

forbes.com

🌐 85% Global Worthiness

Apr 21, 19:14

AI Fitness Wearables: Revolutionizing Athletic Training and Preventative Healthcare

Three experts at an AI conference highlighted breakthroughs in AI fitness wearables: on-device AI processing enhances accessibility and provides real-time physiological data analysis; AI can detect health issues like dehydration more accurately than self-assessment; digital twin technology predicts ...

AI Fitness Wearables: Revolutionizing Athletic Training and Preventative Healthcare

Three experts at an AI conference highlighted breakthroughs in AI fitness wearables: on-device AI processing enhances accessibility and provides real-time physiological data analysis; AI can detect health issues like dehydration more accurately than self-assessment; digital twin technology predicts ...

Progress

28% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How do AI-driven wearable technologies offer superior health insights compared to traditional self-assessment methods?

The shift to edge-device AI processing in wearables allows for the analysis of rich, real-time physiological data, providing more accurate and personalized health and fitness insights than previously possible. This is transforming athletic training and health monitoring by offering granular feedback and early warning systems for conditions like dehydration.

forbes.com

🌐 85% Global Worthiness

Jul 22, 07:14

High-Efficacy Depression Treatment Limited by Access: A Systemic Issue in US Mental Healthcare

A Stanford study showed TMS effectively treats severe depression, but high cost and lack of insurance coverage limit access, highlighting systemic issues in US mental healthcare where innovation outpaces access despite significant investment.

High-Efficacy Depression Treatment Limited by Access: A Systemic Issue in US Mental Healthcare

A Stanford study showed TMS effectively treats severe depression, but high cost and lack of insurance coverage limit access, highlighting systemic issues in US mental healthcare where innovation outpaces access despite significant investment.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does the current mental healthcare system's design contribute to the cycle of multiple failed treatments before patients find relief, and what are the systemic effects?

The current mental healthcare system, designed for acute illnesses, inadequately addresses the complex nature of mental illnesses. This mismatch leads to ineffective treatments, clinician burnout, and high costs, as evidenced by the underutilization of the effective TMS treatment. The lack of comprehensive data further exacerbates the problem, hindering both treatment optimization and risk management by payers.

cincodias.elpais.com

🌐 85% Global Worthiness

Jun 17, 19:17

Lenovo's HPC System Accelerates Cancer and Cardiology Research in Milan

Lenovo provided the IEO Monzino Group in Milan with a 475 TFlop HPC system using Lenovo ThinkSystem servers and NVIDIA H200 GPUs to accelerate cancer and cardiology research, enabling faster analysis of protein interactions and clinical data for improved diagnostics, prognostics, and personalized tr...

Lenovo's HPC System Accelerates Cancer and Cardiology Research in Milan

Lenovo provided the IEO Monzino Group in Milan with a 475 TFlop HPC system using Lenovo ThinkSystem servers and NVIDIA H200 GPUs to accelerate cancer and cardiology research, enabling faster analysis of protein interactions and clinical data for improved diagnostics, prognostics, and personalized tr...

Progress

32% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the primary impact of Lenovo's HPC system on cancer and cardiology research at the IEO Monzino Group?

Lenovo provided the IEO Monzino Group in Milan with a state-of-the-art HPC system to accelerate cancer and cardiology research. This system, reaching 475 TFlops, uses Lenovo ThinkSystem servers and NVIDIA H200 GPUs, enabling advanced predictive modeling and personalized treatment development. The system facilitates faster analysis of large datasets, accelerating the identification of potential drug candidates and biomarkers.

theguardian.com

🌐 90% Global Worthiness

Jun 6, 16:13

Cancer Treatment Breakthroughs Extend Patient Survival

Several breakthroughs in cancer treatment were announced, including new immunotherapies significantly increasing survival rates for head and neck, melanoma, and gastric cancers; Car T-cell therapy showing 40% longer survival in advanced gastric cancer; liquid biopsies enabling faster, personalized t...

Cancer Treatment Breakthroughs Extend Patient Survival

Several breakthroughs in cancer treatment were announced, including new immunotherapies significantly increasing survival rates for head and neck, melanoma, and gastric cancers; Car T-cell therapy showing 40% longer survival in advanced gastric cancer; liquid biopsies enabling faster, personalized t...

Progress

28% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the long-term implications of these breakthroughs for cancer care, and what future research directions are suggested by these findings?

The integration of AI could optimize the use of existing treatments like abiraterone for prostate cancer, eliminating disparities in access to life-extending therapies. Further research into these novel immunotherapies, combined with advancements in diagnostics like liquid biopsies and lifestyle interventions, suggests a paradigm shift in cancer treatment, improving both survival rates and quality of life for patients.

news.sky.com

🌐 90% Global Worthiness

May 30, 07:13

NHS to Roll Out Revolutionary Blood Test for Faster Lung Cancer Diagnosis

The NHS will roll out a new ultra-sensitive blood test, called a liquid biopsy, to help diagnose lung cancer and fast-track patients to targeted treatments, potentially saving £11 million annually and transforming cancer care.

NHS to Roll Out Revolutionary Blood Test for Faster Lung Cancer Diagnosis

The NHS will roll out a new ultra-sensitive blood test, called a liquid biopsy, to help diagnose lung cancer and fast-track patients to targeted treatments, potentially saving £11 million annually and transforming cancer care.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of the new liquid biopsy test on NHS lung cancer patients, and what are the potential cost savings?

A new ultra-sensitive blood test, the liquid biopsy, allows for faster diagnosis of lung cancer by detecting tumor DNA fragments, enabling quicker access to targeted treatments and potentially saving the NHS up to £11 million annually. Thousands of patients will be offered this test, expediting treatment and improving outcomes. Rebeca Proctor's experience highlights the benefit; her liquid biopsy rapidly revealed an ALK mutation, enabling immediate targeted therapy.

forbes.com

🌐 90% Global Worthiness

Apr 22, 16:17

Nucleai's AI-Powered Spatial Biology Revolutionizes Precision Oncology

Nucleai, a Tel Aviv and Chicago-based company founded in 2018, uses AI-powered spatial biology to analyze pathology slides, improving biomarker discovery, patient stratification, and clinical trial outcomes in oncology, particularly for advanced therapies like antibody-drug conjugates (ADCs), and is...

Nucleai's AI-Powered Spatial Biology Revolutionizes Precision Oncology

Nucleai, a Tel Aviv and Chicago-based company founded in 2018, uses AI-powered spatial biology to analyze pathology slides, improving biomarker discovery, patient stratification, and clinical trial outcomes in oncology, particularly for advanced therapies like antibody-drug conjugates (ADCs), and is...

Progress

56% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How is Nucleai's AI-powered spatial biology platform impacting the efficacy and precision of cancer treatment?

Nucleai, an AI-driven spatial biology company, is enhancing precision medicine by analyzing pathology slides to identify biomarkers and stratify patients for more effective cancer treatments. This leads to improved clinical trial response rates and better patient outcomes, particularly with the rise of targeted therapies like antibody-drug conjugates (ADCs).

elpais.com

🌐 90% Global Worthiness

Mar 25, 10:12

AI-Powered Virtual Hearts Prevent Sudden Cardiac Arrest

Dr. Natalia Trayanova, a biomedical engineer, uses AI to create personalized virtual heart models that predict and prevent sudden cardiac arrest, a leading cause of death affecting 400,000 people annually in the US alone.

AI-Powered Virtual Hearts Prevent Sudden Cardiac Arrest

Dr. Natalia Trayanova, a biomedical engineer, uses AI to create personalized virtual heart models that predict and prevent sudden cardiac arrest, a leading cause of death affecting 400,000 people annually in the US alone.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How are virtual heart models created, and what specific data are used to personalize these simulations?

Computational cardiology creates personalized virtual heart models to simulate cardiac function and guide treatment decisions. These models incorporate detailed anatomical data and cellular-level information, enabling precise prediction of arrhythmia risk and treatment outcomes. This approach improves upon traditional methods by offering a personalized, predictive approach to cardiac care.

Showing 1 to 12 of 16 results